The report analyzes and forecasts the thrombin market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of thrombin, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major thrombin companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of thrombin upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of thrombin and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global thrombin market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the thrombin market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of thrombin market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report also profiles key players operating in the thrombin market which are Johnson & Johnson, Pfizer, Inc., Mallinckrodt Pharmaceuticals, Shanghai RAAS blood products co., Ltd., Japan Blood Products Organization and Mochida Pharmaceutical Co., Ltd.
The global thrombin market is segmented as follows:
Global Thrombin market, by Product
Global Thrombin market, by Dosage Form
Global Thrombin market, by End User
Global Thrombin market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1.Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions andAssumptions
2.Executive Summary
3.Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.Key Insights
4.1 Brand Analysis
4.2 Key IndustryDevelopments - Mergers, Acquisitions and Partnerships
4.3 Reimbursement Scenario
4.4 Key PerformanceIndicators
5.Global Thrombin Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis,Insights and Forecast – By Product
5.2.1 Bovine Thrombin
5.2.2 Human Thrombin
5.2.3 Recombinant Thrombin
5.3. Market Analysis,Insights and Forecast – By Dosage Form
5.3.1 Powder Form
5.3.2 Solution Form
5.4. Market Analysis,Insights and Forecast – By End User
5.4.1 Hospitals
5.4.2 Diagnostics Centers & Clinics
5.4.3 Academics and Research Institutes
5.5. Market Analysis,Insights and Forecast – By Region
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Rest of the World
6.North America Thrombin Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis,Insights and Forecast – By Product
6.2.1 Bovine Thrombin
6.2.2 Human Thrombin
6.2.3 Recombinant Thrombin
6.3. Market Analysis,Insights and Forecast – By Dosage Form
6.3.1 Powder Form
6.3.2 Solution Form
6.4. Market Analysis,Insights and Forecast – By End User
6.4.1 Hospitals
6.4.2 Diagnostics Centers & Clinics
6.4.3 Academics and Research Institutes
6.5. Market Analysis,Insights and Forecast – By Country
6.5.1 USA
6.5.2 Canada
7.Europe Thrombin Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis,Insights and Forecast – By Product
7.2.1 Bovine Thrombin
7.2.2 Human Thrombin
7.2.3 Recombinant Thrombin
7.3. Market Analysis,Insights and Forecast – By Dosage Form
7.3.1 Powder Form
7.3.2 Solution Form
7.4. Market Analysis,Insights and Forecast – By End User
7.4.1 Hospitals
7.4.2 Diagnostics Centers & Clinics
7.4.3 Academics and Research Institutes
7.5. Market Analysis,Insights and Forecast – By Country/ Sub-region
7.5.1 UK
7.5.2 Germany
7.5.3 France
7.5.4 Italy
7.5.5 Spain
7.5.6 Rest of the World
8.Asia Pacific Thrombin Market Analysis,Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis,Insights and Forecast – By Product
8.2.1 Bovine Thrombin
8.2.2 Human Thrombin
8.2.3 Recombinant Thrombin
8.3. Market Analysis,Insights and Forecast – By Dosage Form
8.3.1 Powder Form
8.3.2 Solution Form
8.4. Market Analysis,Insights and Forecast – By End User
8.4.1 Hospitals
8.4.2 Diagnostics Centers & Clinics
8.4.3 Academics and Research Institutes
8.5. Market Analysis,Insights and Forecast – By Country/ Sub-region
8.5.1 Japan
8.5.2 China
8.5.3 Australia
8.5.4 Rest of Asia Pacific
9.Rest of the World Thrombin Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis,Insights and Forecast – By Product
9.2.1 Bovine Thrombin
9.2.2 Human Thrombin
9.2.3 Recombinant Thrombin
9.3. Market Analysis, Insights and Forecast – By Dosage Form
9.3.1 Powder Form
9.3.2 Solution Form
9.4. Market Analysis,Insights and Forecast – By End User
9.4.1 Hospitals
9.4.2 Diagnostics Centers& Clinics
9.4.3 Academics and Research Institutes
9.5. Market Analysis,Insights and Forecast – By Country/ Sub-region
10.Competitive Analysis
10.1. Key Industry Developments
10.2. Global Market Share Analysis (2018)
10.3. Competition Dashboard
10.4. Comparative Analysis –Major Players
10.5. Company Profiles(Overview, Products & Services, SWOT Analysis, Recent Developments,Strategies, Financials (based on availability)
10.5.1 Pfizer Inc.
10.5.2 Johnson & Johnson Services Inc.
10.5.3 Baxter
10.5.4 Shanghai RAAS blood products co. Ltd.
10.5.5 Japan Blood Products Organization
10.5.6 Mochida Pharmaceutical Co. Ltd.
10.5.7 Other prominent players
11.Strategic Recommendations